Lipiodol Ultra-Fluid (Ethiodized Oil)

Ethyiodized oil contains a high density of iodine atoms, which absorb X‑ray photons. When administered intralymphatically, the oil remains within lymphatic channels, creating a persistent radiopaque column that outlines vessels and nodes on X‑ray or CT images, thereby improving visualization of the lymphatic anatomy.

The dose of Lipiodol Ultra-Fluid is determined by the prescribing physician based on the specific imaging procedure, patient size, and clinical objectives. No fixed regimen is provided; the healthcare professional calculates the appropriate volume at the time of the intervention.

Safety data for Lipiodol Ultra-Fluid in pregnancy and lactation are limited. It is generally avoided during pregnancy unless the diagnostic benefit outweighs potential risks to the fetus. Breastfeeding mothers should consult their physician, as the product may be excreted in milk.

To order Lipiodol Ultra-Fluid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Compared with water‑soluble iodinated contrast agents, Lipiodol Ultra-Fluid is oil‑based, which gives it longer retention in the lymphatic system and higher radiopacity. This makes it especially useful for procedures requiring prolonged imaging, such as sentinel node mapping, but it may have a higher risk of oil‑related adverse events.

Store Lipiodol Ultra-Fluid at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the product from direct sunlight, excessive heat, and moisture. Do not freeze or shake the vial before use, and keep it out of reach of children.

Lipiodol Ultra-Fluid is administered by intralymphatic injection under imaging guidance. A trained radiologist or interventional specialist injects the liquid directly into lymphatic vessels or nodes using a fine needle or catheter, allowing the contrast to flow through the lymphatic system for diagnostic imaging.

The most serious risks include severe allergic reactions such as anaphylaxis, oil embolism that can obstruct pulmonary or cerebral vessels, and tissue necrosis at the injection site. Patients should be monitored closely during and after administration for any signs of these complications.

Lipiodol Ultra-Fluid should be avoided in individuals with known hypersensitivity to iodine or oil‑based contrast agents, in patients with severe uncontrolled thyroid disease, and in those with compromised renal function where additional iodine load could be harmful. Contraindications must be confirmed by the treating physician.